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Summary Women with breast cancer and a family history of breast cancer and some with sporadic breast
cancer are deficient in the repair of radiation-induced DNA damage compared with normal donors with no
family history of breast cancer. DNA repair was measured indirectly by quantifying chromatid breaks in
phytohaemagglutinin (PHA)-stimulated blood lymphocytes after either X-irradiation or UV-C exposure, with
or without post treatment with the DNA repair inhibitor, l-fl-D-arabinofuranosylcytosine (ara-C). We have
correlated chromatid breaks with unrepaired DNA strand breaks using responses to X-irradiation ofcells from
xeroderma pigmentosum patients with well-characterised DNA repair defects or responses of repair-deficient
mutant Chinese hamster ovary (CHO) cells with or without transfected human DNA repair genes. Deficient
DNA repair appears to be a predisposing factor in familial breast cancer and in some sporadic breast cancers.
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The DNA of mammalian cells is continually subject to
exogenous and endogenous damaging agents. Radiations
from the sun or other sources, chemical mutagens in the
atmosphere, foods or drugs, as well as normal metabolites
such as hydrogen peroxide and its derivative, *OH, can
produce DNA lesions. These lesions, if not repaired, can have
serious consequences, resulting in infidelity of replication,
mutations, neoplastic transformation and even cell death.
Cellular repair mechanisms involving multienzymatic steps
have evolved to remove these lesions. Monitoring and repair
of DNA damage sustained during G2 phase just before
mitosis and distribution of chromosomes to daughter cells
appears to play an important role in carcinogenesis.
An abnormally high chromatid break frequency in cells
entering metaphase 0.5-1.5 h after X-irradiation was
observed in fibroblasts or peripheral blood lymphocytes
from individuals with any one of 12 cancer-prone genetic
disorders (Sanford et al., 1989; 1993; Parshad et al., 1993a).
The findings on many of these have now been confirmed and
three more cancer-prone conditions have been found to have
the abnormality (De Bauche et al., 1990; Scott et al., 1994).
This abnormality has been interpreted as resulting from an
inherent alteration in chromatin structure (Pandita and
Hittelman, 1995), a higher rate of conversion of double-
strand breaks to chromatid breaks (Mozdarani and Bryant,
1989) or from deficient DNA repair (Sanford et al., 1989 and
Parshad et al., 1983). Furthermore, Scott et al. (1994) have
reported an abnormally high frequency of chromatid breaks
after G2 phase X-irradiation in PHA-stimulated lymphocytes
from 21 of an unselected series of 50 women with apparently
sporadic breast cancer. They suggest that predisposing genes
for breast cancer are involved in the processing of DNA
damage.
Blood lymphocytes or fibroblasts in culture from normal
donors and from individuals with a cancer-prone genetic
disorder except A-T had equivalent chromatid break
frequency when entering metaphase during the first 0.5 h
after X-irradiation (Parshad et al., 1983, 1993b; Sanford et
al., 1987, 1990; Takai et al., 1990). This result indicates
similar initial radiosensitivities, i.e. equivalent amounts of
initial damage induced by the X-irradiation. Cells from
normal donors entering metaphase during the subsequent
hour (0.5 to 1.5 h) showed a precipitous decline in chromatid
break frequency, whereas those from cancer-prone donors
maintained a high or even an increased frequency level
(Parshad et al., 1983, 1993a; Sanford et al., 1987, 1990; Takai
et al., 1990). This differential response apparently does not
result from a more rapid transit of the cancer-prone cells
through G2 allowing less time to repair the radiation-induced
DNA damage; the percentage of irradiated relative to non-
irradiated metaphase cells declined at the same rate in cells
from both cancer-prone and normal donors and both showed
a complete mitotic block at 2 h after irradiation (Parshad et
al., 1983; De Bauche et al., 1990). The decline in chromatid
break frequency characterising cells from normal donors
apparently results from efficient repair of the underlying
DNA damage induced directly or indirectly by the
irradiation. This concept is supported by the fact that
addition of the DNA repair inhibitor, 1-/B-D arabinofurano-
sylcytosine (ara-C), which inhibits the polymerase step in
excision repair, can prevent the decline and result in increased
chromatid breaks at various intervals within 3 h after X-
irradiation (Preston et al., 1992; Sanford et al., 1993; Parshad
et al., 1993b). These results suggest that the X-ray-induced
DNA lesions leading to chromatid breaks are repaired during
this time period through an excision repair pathway in which
the DNA is enzymatically incised to remove damaged sites
(Friedburg et al., 1995). In contrast to cells from normal
donors, cells from certain cancer-prone individuals showed
little ara-C effect on chromatid break frequency (Preston et
al., 1992; Sanford et al., 1993; Parshad et al., 1993b). These
results suggest that the cells are deficient in DNA repair.
To justify the use of chromatid break frequency after G2
phase DNA damage as a measure of DNA repair capacity,
we have examined such responses in cells with well-
characterised defects in DNA repair. These include cells
from xeroderma pigmentosum (XP) patients defective in
repair of oxygen free radical-induced lesions (Satoh et al.,
1993) and CHO mutant cells with and without transfected
human DNA repair genes. We then determined chromatid
aberration frequencies after G2 phase X-irradiation (0.48 Gy)
in phytohaemagglutinin (PHA)-stimulated peripheral blood
lymphocytes from breast cancer patients with or without a
family history of breast cancer, from patients with
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preinvasive breast lesions and from normal donors. The
results show that deficient repair of the radiation-induced
DNA damage is a predisposing factor in familial breast
cancer and in some of its sporadic forms.
Materials and methods
Coded blood samples from the normal control donors and
from patients with breast lesions were provided by our
collaborators. Whereas the control donors were carefully
screened, healthy, non-institutionalised subjects, all patients
were participants of an ongoing study (NIH Protocol
Number 94C-0056) and were sampled before commencement
of therapy. In addition, coded samples of blood from three
normal donors and two XP patients were kindly provided by
Dr K H Kraemer, NCI; some results on these were published
previously (Parshad et al., 1993b).
Mutant CHO cells 27-1 and UV-61 and their derivatives
transfected with human DNA repair genes ERCC3 and
ERCC6 using pSV3 gpt as vector have been described
(Vermeulen et al., 1994; Troelstra et al., 1993). In repeated
experiments the vector alone did not affect DNA repair in the
mutant cells (Weeda et al., 1990; Troelstra et al., 1992).
Cultures of these cells were coded by VAB at Baltimore and
sent by mail to Bethesda where experiments were conducted.
Experimental procedures
The procedure for X-irradiating 72 h cultures of PHA-
stimulated peripheral blood lymphocytes has been described
previously (Sanford et al., 1990). Briefly, we added 3.5 ml of
freshly drawn blood to a T-25 flask containing 35 ml of
RPMI-1640 with 15% fetal bovine serum (FBS) with
10 U ml-' heparin, 0.1 mg ml-' gentamicin and 1% (v/v)
PHA (HA 15, Burroughs-Wellcome, Research Triangle Park,
NC, USA). The medium was equilibrated with 10% carbon
dioxide in air to adjust the pH and was warmed at 37°C
before addition of the blood sample. The culture was
incubated upright and inverted every 24 h to resuspend
cells. After 72 h incubation, cells were X-irradiated as a
concentrated suspension of predetermined cell density in 2 ml
of medium in a 15 ml borosilicate centrifuge tube at a dose
rate of 0.43 Gy min-', total dose 0.48 Gy. The tube was
positioned at an angle of 350 on a T-150 flask containing
water at 37°C. The pellet was then resuspended in 9 ml of the
medium, incubated for 0.5 h and treated with 0.1 jIg colcemid
ml-' for 1 h before processing for chromosome analysis.
Some of the cultures received ara-C as indicated (Table I).
Stock lines of CHO cells were maintained as described for
fibroblasts (Parshad et al., 1993a). For UV exposures, 24 h
cultures of cells in 50 mm plastic Petri dishes were irradiated
in phosphate-buffered saline (PBS) at 37°C with 12 J m-2 at
254 nm UV (General Electric germicidal lamp G15T8) at an
incident flux of 2 J m-2 s-'. The PBS was immediately
replaced by 10 ml of culture medium [Dulbecco's modified
Eagle medium (DMEM) + 10% FBS] and cultures transferred
to a carbon dioxide incubator. At 30 min after irradiation
some cultures received ara-C, whereas all received colcemid
for an additional 1 h to arrest cells at metaphase.
Chromosome analysis
All experiments were carried out in the In Vitro Carcinogen-
esis Section of the National Cancer Institute (NCI). The
coded preparations were analysed at Howard University and
decoded at NCI only after the data had been tabulated; 50-
100 metaphase cells were examined per variable. Aberrations
scored as chromatid breaks showed either non-alignment and
displacement of the broken segment (i.e. displaced breaks) or
a discontinuity longer than the chromatid width (i.e. non-
displaced breaks).
Results
Responses of XP cells to X-irradiation
Table I compares the cytogenetic responses to X-irradiation
of PHA-stimulated peripheral blood lymphocytes from three
normal donors with those from an XP-C and XP-A patient.
Chromatid breaks were compared in cells entering metaphase
0.5-1.5 h after irradiation in the absence or presence of the
DNA repair inhibitor ara-C. In the absence of ara-C, cells
from all three normal donors show a low frequency of
chromatid breaks compared with that of the cancer-prone XP
cells. However in the presence of ara-C, cells from normal
donors show a mean ara-C effect of 247+10 (range 228 -258)
compared with a low ara-C effect of six and 42 in cells from
XP-A and XP-C respectively.
Responses of CHO cells with or without human DNA repair
genes to UV
To establish further the relationship between frequency of
chromatid breaks and DNA repair, we examined the
responses to UV of mutant CHO cells with and without
transfected human repair genes, ERCC3 (XPB) (Vermeulen
et al., 1994) or ERCC6 (CSB) (Troelstra et al., 1993). These
mutant cell lines of groups 1 and 6 (Collins, 1993) are known
to have abnormally low incision activity to remove UV-
Table I Chromatid breaks with and without ara-C 0.5- 1.5h after G2 phase X-irradiation (0.48 Gy)
in normal and XP peripheral blood lymphocytes
Chromatid breaks per 100 metaphase cells
UV-induced UDSVC
Percentage of (Percentage of
Donor No Ara-C Ara-Ca Ara-C effect" normal normal)
Normal
11965 40 268 228
12279 38 294 256
12258 40 298 258 - -
Mean (SE) 39.3+0.7 286.7+ 10.0 247.3+10.0 100.0 100.0
XP-C
XP1BE 92 134 42 17.0 10-20
XP-A
XP12BE 70 76 6 2.4 1
aAra-C (50gM) added with colcemid 0.5 to 1.5h after irradiation. At thisconcentration, ara-C in the
absence ofirradiation caused <9 chromatid breaks per 100 metaphase cells (unpublished). bChromatid
break frequency with ara-Cminusfrequencywithoutara-C.CUDS, unscheduled DNAsynthesis measure
ofDNA repair synthesis during interphase.induced DNA damage. In the absence of the transfected
genes the ara-C effect was low, -4 and 2 compared with 78
and 98 with transfected genes to restore incision activity
(Table II).
Responses of PHA-stimulated blood lymphocytes from normal
and cancer patients to X-irradiation
Figure 1 presents the chromatid break frequencies of
peripheral blood lymphocytes entering metaphase 0.5-1.5 h
after irradiation from: A and B, 13 normal donors (ages 28-
79 years), three with a family history of breast cancer; C and
D, eight patients with preinvasive breast lesions (ages 40-54
years), one with a family history of breast cancer; and E and
F 19 breast cancer patients (ages 28-74 years), each from a
different family, 12 without and seven with a family history
of breast cancer. A family history of breast cancer is defined
as having one first-degree relative with breast cancer or two
or more second-degree relatives with breast or ovarian cancer
and at least one with breast cancer. The patients with
preinvasive breast lesions include five with lobular carcinoma
in situ and two with ductal carcinoma in situ. In nine of the
ten normal donors, the chromatid break frequency was <60.
This low level has been observed by us in skin fibroblasts or
peripheral blood lymphocytes from 133 of 136 (- 98%)
normal donors with no family history of cancer aged 1-96
years (no age effect). Of the three normal donors with a
family history of breast cancer (Figure 1) one had a
chromatid break frequency <60, whereas the other two
had frequencies of 104 and 178. The seven patients, each with
a preinvasive breast lesion (age 41-52) had an average
frequency of 146, range 120-178. Cells from one patient with
preinvasive lesion and a family history of breast cancer had a
frequency of 122. Cells from six breast cancer patients with
no family history of cancer (age 38-74) responded like those
from normal donors with a chromatid break frequency <60,
whereas the remaining six (age 37-74) had a frequency
ranging from 113 to 362. Of seven breast cancer patients (age
38-66) with a family history of breast cancer, one responded
as normal with a frequency of 48 while the remaining six had
a frequency ranging from 116 to 158 (Figure 1).
Cells from the one familial breast cancer patient showing a
normal response to X-irradiation (chromatid break frequency
<60, Figure 1) were exposed to UV-C (12 J) another DNA-
damaging agent. Table III shows that cells from this patient
have an ara-C effect of 2 compared with 44-80 for cells from
six cancer-free donors. This result indicates an abnormally
low incision activity for removal of UV-induced DNA
damage.
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irradiation than that in cells from donors with no family
history of breast cancer. Of the two individuals with a family
history and a low chromatid break frequency (<60 after G2
X-irradiation), only one had cancer. Cells from this
individual after UV-C exposure, like those from XP-A,
showed a minimal increase in chromatid breaks with ara-C
treatment (Table III). XP-A and C cells are known to be
defective in incision and removal of cyclobutane pyrimidine
dimers in the overall genome (Evans et al., 1993). XP-A cells
are also defective in removal of dimers from an active gene,
whereas XP-C cells remove dimers normally from the
transcribed strand of an active gene, but the non-transcribed
strand is not repaired significantly in these cells (Evans et al.,
1993). Thus, the responses of XP cells to X-irradiation in the
chromosomal assay correlate to some extent with their
responses to UV-induced damage. The ara-C effects of XP-
C and XP-A cells, expressed as 17% and 2.4% of normal
respectively, correlate extremely well with levels of repair of
UV-induced damage of 10-20% and 1% respectively, (Table
I), as measured by unscheduled DNA synthesis (UDS)
(Robbins et al., 1974; Kraemer et al., 1975 and Petinga et
al., 1977). Furthermore, the ara-C effect in CHO cells with or
without human DNA repair genes correlates with the known
incision activity of the cells. XP cells, usually resistant to
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Chromatid breaks per 100 metaphase cells Discussion
Frequencies of chromatid breaks in blood lymphocytes from
9 of 11 individuals with a family history of breast cancer, six
with breast cancer, one with preinvasive breast lesions and
two with no cancer, was 2-3 fold higher after G2 phase X-
Table H Effect of ara-C (5SOUM) on chromatid breaks in UV-C-
irradiated (1OJ) CHO cells with and without transfected human
repair genes
Chromatid breaks per 100 metaphase cells
Cell line Transfected gene No ara-C Ara-C' Ara-C effect
27-1 - 30 26 -4
ERCC-3
(XPB) 8 86 78
UV-61 14 16 2
ERCC-6
(CSB) 10 108 98
aAra-C (50gM) added with colcemid 0.5- 1.5 h after irradiation.
Figure 1 Chromatid breaks in PHA-stimulated blood lympho-
cytes after X-ray-induced DNA damage during G2. *Reported
previously in Knight et al. (1993).
Table HI Effect of ara-C on frequency of chromatid breaks in
blood lymphocytes from normal donors and breast cancer patient
after UV-C exposure
Chromatid breaks per 100 metaphase cells
Donor No Ara-C Ara-Cz Ara-C Effect
Normal
13 651 6 86 80
13 662 3 (2,4) 68 (66,70) 65
13681 6 50 44
13 792 2 50 48
13 884 2 54 52
13926 2 62 60
Cancer patient
13 927 10 12 2
aAra-C (S5uM) added at 10min after UV and colcemid at 30min
after irradiation for 2h.
~~~.
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ionising radiation, are thought to repair X-ray lesions
normally. However, Satoh et al. (1993) reported a DNA
excision-repair defect in XP (complementation groups A, B,
C) that prevents removal of at least one type of oxygen free
radical-induced base lesion. These lesions are repaired by the
nucleotide excision repair (NER) process. NER requires
enzymatic incision of the damaged DNA strand, removal of
the damaged and neighboring nucleotides, repair replication
by a polymerase to fill the space and ligation of the strand
(Preston, 1980; Squires and Johnson, 1988; Hoeijmakers and
Bootsma, 1994). Inhibition of the polymerase step by ara-C
results in an accumulation of DNA strand breaks which, if
unrepaired, are processed into chromatid breaks manifest at
the subsequent metaphase (Natarajan et al., 1980; Preston,
1980). In the absence of ara-C, the high frequency of
chromatid breaks in XP-A and C cells after X-irradiation
(Table 1) indicates a deficiency in repair of DNA strand
breaks, either those produced directly by the X-irradiation or,
more likely, because of the repair kinetics, those arising later
during NER. The deficiency could be in ligation or in any
one of the enzymatic steps following incision that leads to
ligation. This chromosomal response was not seen, with few
exceptions, in cells from normal healthy control donors.
Thus, it appears that cells from 10 of 11 individuals with a
family history of breast cancer have a deficiency in the
processing of X-ray- or UV-induced DNA damage, manifest
as an abnormally high frequency of chromatid breaks or a
reduced capacity for DNA incision, an early step in NER. A
similar deficiency in the repair of X-ray-induce damage is
reported in skin fibroblasts or peripheral blood lymphocytes
from 56 obligate ataxia telangiectasia heterozygotes (Parshad
et al., 1985; Sanford et al., 1990; Scott et al., 1994), who are
at a 4-fold (range 2- to 7-fold) increase in relative risk of
breast cancer (Easton, 1994). Furthermore, in a family with
Li-Fraumeni syndrome, members with diverse cancers
including those of breast, brain and other soft tissue showed
a similar response to X-ray-induced DNA damage (Parshad
et al., 1993a). One affected individual in this family was
clinically normal at the time of biopsy to initiate the cell line
studied, but developed two primary breast cancers later.
Members of this particular family also carry a p53 germline
mutation (Srivastava et al., 1990). Mutated p53 has been
associated with breast and other cancers (Buller et al., 1993;
Eyfj6rd et al., 1995), moreover, it has recently been
implicated in the repair of DNA damage (Smith et al.,
1995; Wang et al., 1995) and genomic instability in primary
human breast carcinomas (Eyfj6rd et al., 1995). Furthermore,
we showed previously that epithelial cells derived from
human skin or normal human mammary tissue acquired a
deficiency in repair of X-ray-induced DNA damage before
they could be transformed in culture by chemicals or viruses
to malignant cells, as evidenced by their growth as
carcinomas in nude mice. These results seem to indate
that deficient DNA repair is a prerequisite for carcinogenesis
(Gantt et al., 1987; Sanford et al., 1992; Parshad et al., 1994).
Thus, deficient DNA repair, manifest as an abnormally high
frequency of chromatid breaks or low activity for incision of
UV-induced DNA damag, appears to be a predisposing
factor in familial breast cancer. As some women with
sporadic breast cancer also have such a deficiency, as shown
here and earLer (Scott et al., 1994), deficient DNA repair
may be a predisposing factor in the development of certain
sporadic breast cancers.
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